Consolidated statement of financial position
In thousands of euro (before profit appropriation) | Note | 31 December 2018 | 31 December 2017 |
Assets | |||
Property, plant and equipment | 17 | 261,555 | 205,904 |
Intangible assets and goodwill | 18 | 168,023 | 96,229 |
Investment property | 19 | 643 | 830 |
Trade and other receivables | 21 | 13,690 | 9,298 |
Equity-accounted investees | 20 | 25,392 | 24,018 |
Deferred tax assets | 16 | 2,099 | 2,998 |
Non-current assets | 471,402 | 339,277 | |
Inventories | 22 | 93,555 | 72,010 |
Biological assets | 23 | 4,314 | 4,714 |
Trade and other receivables | 21 | 250,618 | 208,170 |
Current tax assets | 16 | 2,072 | 86 |
Cash and cash equivalents | 24 | 51,756 | 161,297 |
Assets held for sale | 25 | - | 1,737 |
Current assets | 402,315 | 448,014 | |
Total assets | 873,717 | 787,291 | |
Equity | |||
Share capital | 1,063 | 1,063 | |
Share premium | 143,554 | 143,554 | |
Treasury share reserve | -61 | -55 | |
Translation reserve | -6,653 | -5,692 | |
Hedging reserve | -896 | - | |
Other reserves and retained earnings | 239,990 | 207,878 | |
Unappropriated result | 58,590 | 58,554 | |
Equity attributable to shareholders of the Company | 26 | 435,587 | 405,302 |
Non-controlling interests | 34 | 5,166 | 4,629 |
Total equity | 440,753 | 409,931 | |
Liabilities | |||
Loans and borrowings | 29 | 52,540 | 44,508 |
Employee benefits | 15 | 33,496 | 46,910 |
Provisions | 30 | 2,024 | 2,249 |
Trade and other payables | 31 | 41,258 | 8,255 |
Deferred tax liabilities | 16 | 13,174 | 9,939 |
Non-current liabilities | 142,492 | 111,861 | |
Bank overdrafts | 24 | 13,307 | 49,690 |
Loans and borrowings | 29 | 2,963 | 28 |
Provisions | 30 | 1,372 | 1,132 |
Trade and other payables | 31 | 267,695 | 206,982 |
Current tax liability | 16 | 5,135 | 7,667 |
Current liabilities | 290,472 | 265,499 | |
Total liabilities | 432,964 | 377,360 | |
Total equity and liabilities | 873,717 | 787,291 | |
The notes 1 to 52 are an integral part of these consolidated financial statements.